Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Market Cap: 457.1m GBX
Have any thoughts about
Amryt Pharma Holdings Ltd?
Write Note

Amryt Pharma Holdings Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amryt Pharma Holdings Ltd
Operating Expenses Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Amryt Pharma Holdings Ltd
LSE:AMYT
Operating Expenses
-$109m
CAGR 3-Years
-63%
CAGR 5-Years
-131%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Operating Expenses
-ÂŁ15.3B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
AstraZeneca PLC
LSE:AZN
Operating Expenses
-$30.1B
CAGR 3-Years
-18%
CAGR 5-Years
-16%
CAGR 10-Years
-5%
Verona Pharma PLC
NASDAQ:VRNA
Operating Expenses
-$160.5m
CAGR 3-Years
-17%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Expenses
-$813m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Expenses
-ÂŁ404.7m
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
-17%

See Also

What is Amryt Pharma Holdings Ltd's Operating Expenses?
Operating Expenses
-109m USD

Based on the financial report for Dec 31, 2020, Amryt Pharma Holdings Ltd's Operating Expenses amounts to -109m USD.

What is Amryt Pharma Holdings Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-131%

Over the last year, the Operating Expenses growth was -109%. The average annual Operating Expenses growth rates for Amryt Pharma Holdings Ltd have been -63% over the past three years , -131% over the past five years .

Back to Top